stoxline Quote Chart Rank Option Currency Glossary
  
CONMED Corporation (CNMD)
64.37  1.87 (2.99%)    02-13 16:00
Open: 62.95
High: 64.5
Volume: 508,997
  
Pre. Close: 62.5
Low: 62.315
Market Cap: 1,988(M)
Technical analysis
2025-02-13 4:46:59 PM
Short term     
Mid term     
Targets 6-month :  81.39 1-year :  87.16
Resists First :  69.69 Second :  74.62
Pivot price 69
Supports First :  61.7 Second :  51.33
MAs MA(5) :  65.13 MA(20) :  69
MA(100) :  69.76 MA(250) :  71.93
MACD MACD :  -1.3 Signal :  -0.5
%K %D K(14,3) :  10.6 D(3) :  11.1
RSI RSI(14): 39
52-week High :  86.95 Low :  61.04
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ CNMD ] has closed above bottom band by 14.3%. Bollinger Bands are 44.8% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 0 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 64.59 - 64.95 64.95 - 65.28
Low: 61.37 - 61.84 61.84 - 62.27
Close: 63.68 - 64.37 64.37 - 65.01
Company Description

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

Headline News

Thu, 13 Feb 2025
Conmed's chief information officer sells $16,796 in common stock - MSN

Wed, 12 Feb 2025
Legato Capital Management LLC Purchases 7,997 Shares of CONMED Co. (NYSE:CNMD) - MarketBeat

Tue, 11 Feb 2025
abrdn plc Has $9.40 Million Holdings in CONMED Co. (NYSE:CNMD) - MarketBeat

Mon, 10 Feb 2025
Needham cuts CONMED stock target to $91, maintains Buy rating - MSN

Sat, 08 Feb 2025
CONMED Corporation Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - Simply Wall St

Sat, 08 Feb 2025
CONMED Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Healthcare
Industry:
Medical - Devices
Shares Out 31 (M)
Shares Float 31 (M)
Held by Insiders 0.5 (%)
Held by Institutions 114.7 (%)
Shares Short 2,330 (K)
Shares Short P.Month 2,380 (K)
Stock Financials
EPS 4.21
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 30.2
Profit Margin 10.2 %
Operating Margin 12.2 %
Return on Assets (ttm) 3.9 %
Return on Equity (ttm) 15.2 %
Qtrly Rev. Growth 4 %
Gross Profit (p.s.) 23.27
Sales Per Share 41.76
EBITDA (p.s.) 7.05
Qtrly Earnings Growth 214 %
Operating Cash Flow 180 (M)
Levered Free Cash Flow 126 (M)
Stock Valuations
PE Ratio 15.25
PEG Ratio 0
Price to Book value 2.13
Price to Sales 1.54
Price to Cash Flow 11.04
Stock Dividends
Dividend 0.2
Forward Dividend 0
Dividend Yield 0.3%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android